After a lengthy review, the U.S. Pharmacopeia (USP) has decided to continue recommending the use of decades-old reagents derived from horseshoe crab blood for detecting endotoxins in drugs rather than press for the use of new synthetic substitutes.

The European Commission is asking for comments on a new, wide-ranging strategy aimed at ensuring patients have access to safe, affordable and high-quality drugs across Europe.

A Texas study of convalescent plasma as a treatment for critically ill COVID-19 patients found the blood-based treatment to be safe for severely infected patients.